Peginterferon alfa-2a (Pegasys)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Peginterferon alfa-2a (Pegasys), covering 2007-04-23 to 2008-10-01. Get the full timeline:
Most recent: Clinical Trial Update: 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C [Phase 2]